Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

W

Washington State University

Other

0

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

0

Indications↗

Distinct diseases across all programs

24

Clinical Trials↗

All sponsored trials (all statuses)

Activity

Recent Activity

Last 14 days

Sleep Loss and Circadian Misalignment - Mechanisms of Insulin Resistance

Native Women's Wellness: Contingency Management for Tobacco Cessation and Weight Loss

Innovations in Enhancing Colorectal Cancer Screening

Earlier

Aug 25, 2026TrialEvaluating the Pharmacokinetics and Drug Interaction Potential of the Botanical Dietary Supplement Cinnamon

Aug 4, 2026TrialA Family Peer Navigator Model to Increase Access and Initial Engagement in Coordinated Specialty Care Programs Among Black Families

Jul 7, 2026TrialPharmaceutically-Enhanced Reinforcement for Reduced Alcohol and Smoking

Jul 7, 2026TrialAutomated Reinforcement Management Systems, Phase II

Jul 7, 2026TrialZonisamide for the Treatment of Alcohol Use Disorder in the Addiction Neuroclinical Assessment Framework

4 more events

Jul 3, 2026TrialA Phase II Randomized, Double-blind, Placebo-controlled Clinical Trial (RCT) to Evaluate the Ability of Mirtazapine (MZP) to Increase Methamphetamine (MA) Abstinence Among Treatment-seeking Medication for Opioid Use Disorder (MOUD) Adults

Feb 11, 2026TrialEffects of Hemp-Derived Cannabinoids on Menopause Symptoms

Feb 1, 2026TrialAcute Effects of Cannabis on Cognition and Affect

Sep 26, 2024TrialEvaluating the Pharmacokinetics of Oregano and Potential Oregano-drug Interactions Using a Drug Cocktail Approach

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)